Transparency data

UK NSC agenda November 2022

Updated 5 May 2023

漏 Crown copyright 2023

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: [email protected].

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at /government/publications/uk-nsc-meeting-november-2022/uk-nsc-agenda-november-2022

1. Introduction and apologies

2. Call for new interests

3. Minutes of the last meeting

4. UK NSC expanded remit and adoption of the Chief Medical Officers鈥� (颁惭翱蝉鈥�) recommendations

4.1 Recommendation 5 鈥� terms of reference for the creation of a feasibility assessment group

4.2 Recommendation 6b 鈥� patient and public voice (PPV)

5. Matters arising 鈥� Director鈥檚 update

5.1 In-service evaluation on non-invasive prenatal testing (NIPT)

5.2 In-service evaluation on severe combined immunodeficiency (SCID)

5.3 Cervical screening intervals

5.4 Targeted lung cancer screening update

6. UK NSC website and blog analytics

7. Stakeholder activity update

8. Report on international consensus on informed choice

9. Fetal, maternal and child health (FMCH) screening

9.1 FMCH group minutes

9.2 Tyrosinaemia 鈥� further modelling

9.3 Evidence summary 鈥� screening for autism spectrum disorder

9.4 Evidence summary 鈥� antenatal screening for the prevention and prediction of pre-eclampsia

9.5 Evidence map 鈥� iron deficiency in children

9.6 Evidence map 鈥� antenatal screening for Human T-cell lymphotropic virus (HTLV)

10. Adult screening

10.1 Adult reference group (ARG) minutes

11. Update on the research methodology group (RMG)

12. Any other business

Back to top